Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.63NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FM.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GA.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GK.1.10.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-21359South Korea
EG.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GN.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.13.3.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
GW.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.424NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.64NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AH.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.327NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.396NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.129NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AK.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.221.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.224NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.14NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.618NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.458NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.17NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AG.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
W.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.264.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.21 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.20NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.19NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.12NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AT.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.619.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
P.1.12.1 (Gamma)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AZ.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.260NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.456NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.160.16NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.4.16 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
BA.1.22NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.70NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.177.42NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.428NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.374NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
AY.63 (Delta)NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.377NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.258.15NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
B.1.1.298NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
C.30.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used